18F-deoxyglucose positron emission tomography (FDG-PET) for the planning of radiotherapy in lung cancer: High impact in patients with atelectasis

International Journal of Radiation Oncology Biology Physics

Volumn 44, Issue 3, 1999, Pages 593-597

  Nestle, Ursula ^a   Walter, Karin ^a   Schmidt, Sylvia ^a   Licht, Norbert ^a   Nieder, Carsten ^a   Motaref, Babak ^a   Hellwig, Dirk ^a   Niewald, Marcus ^a   Ukena, Dieter ^a   Kirsch, Carl M ^a   Sybrecht, Gerhard W ^a   Schnabel, Klaus ^a  

^a SAARLAND UNIVERSITY   (Germany)

Author keywords

Atelectasis; Lung cancer; PET; Planning; Radiotherapy

Indexed keywords

FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

ARTICLE; ATELECTASIS; CANCER STAGING; CLINICAL ARTICLE; DIAGNOSTIC VALUE; HUMAN; LUNG CANCER; LUNG SCINTISCANNING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT PLANNING; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED RADIOTHERAPY; COMPUTER ASSISTED TOMOGRAPHY; LUNG NON SMALL CELL CANCER; LUNG TUMOR; METHODOLOGY; RETROSPECTIVE STUDY; SCINTISCANNING;

ATELECTASIS; CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; RADIOPHARMACEUTICALS; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RETROSPECTIVE STUDIES; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0032586962     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0360-3016(99)00061-9     Document Type: Article

References (20)

1. Vansteenkiste J.F., Stroobants S.G., DeLeyn P.R., et al. Mediastinal lymph node staging with FDG-PET scan in patients with potentially operable non-small-cell lung cancer: A prospective analysis of 50 cases. Leuven Lung Cancer Group. Chest. 112:1997;1480-1486.
2. Guhlmann A., Storck M., Kotzerke J., et al. Lymph node staging in non small cell lung cancer: Evaluation by 18F FDG positron emission tomography (PET). Thorax. 52:1997;438-441.
3. Steinert H.C., Hauser M., Allemann F., et al. Non-small cell lung cancer: Nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling. Radiology. 202:1997;441-446.
4. Bury T., Paulus P., Dowlati A., et al. Staging of the mediastinum: Value of positron emission tomography imaging in non-small cell lung cancer. Eur Resp J. 9:1996;2560-2564.
5. Hebert M.E., Lowe V.J., Hoffmann J.M., et al. Positron emission tomography in the pretreatment evaluation and follow-up of non-small cell lung cancer patients treated with radiotherapy: Preliminary findings. Am J Clin Oncol. 19:1996;416-421.
6. 18FDG PET scans. Radiology. 201:1996;873-876.
7. 18F-FDG in a brain abscess: A PET study. J Comput Assist Tomogr. 13:1990;829-831.
8. Kubota R., Yamada S., Kubota K., et al. Intratumoral distribution of F-18 fluorodeoxyglucose in vivo: High accumulation in macrophages and granulation tissues studied by microautoradiography. J Nucl Med. 33:1992;1972-1980.
9. 18F-FDG-PET. J Nucl Med. 19:1996;416-421.
10. Munley M.T., Scarfone M.S., Marks L.B., et al. Multimodality nuclear medicine imaging in radiation treatment planning for lung cancer: Challenges and prospects. Int J Radiat Oncol Biol Phys. 36:1996;188.
11. 18F-fluoro-deoxyglugose positron emission tomographic imaging to radiotherapy planning in lung cancer. Lung Cancer. 19:1998;167-177.
12. Debois M., Fossard A., Vansteenkiste J., et al. Impact of PET scan in lung cancer radiotherapy planning. (Abstr.) Radiotherapy and Oncology. 48:(Suppl. 1):1998;S13.
13. Emami B., Scott C., Byhardt R., et al. The value of regional nodal radiotherapy (dose/volume) in the treatment of unresectable non small cell lung cancer: An RTOG analysis. Int J Radiat Oncol Biol Phys. 36:(Suppl.):1996;209.
14. Graham M.V., Purdy J.A., Emami B., et al. Preliminary results of a prospective trial using three dimensional radiotherapy for lung cancer. Int J Radiat Oncol Biol Phys. 33:1995;993-1000.
15. Stuschke M. Lung cancer: Role of nodal irradiation - "Fletcher." (Abstr.) Radiother Oncol. 48:(Suppl.1):1998;S58.
16. Stout R. The role of nodal irradiation in curative radiotherapy - "Manchester" (Abstr.) Radiother Oncol 1998;48(Suppl.1):S58.
17. Ukena D., Rentz K., Leutz M., et al. Evaluation of lung cancer with FDG-positron emission tomography (PET). (Abstr.) Eur Resp J. 12:(Suppl.):1998;393S.
18. Ekberg L., Holmberg O., Wittgren L., et al. What margins should be added to the clinical target volume in radiotherapy treatment planning for lung cancer? Radiother Oncol. 48:1998;71-77.
19. Gross M.W., Feldmann H.J., Bartenstein P., et al. The value of F-18-fluorodesoxyglucose PET for the 3-D radiation treatment planning of malignant gliomas. Int J Radiat Oncol Biol Phys. 41:1998;989-995.
20. Rahn A., Baum R., Adamietz I., et al. Application of FDG-positron emission tomography in radiation treatment planning of head and neck tumors. Strahlenther Onkol. 174:1998;358-364.